The University of Michigan | |||||
July
10, 2002
Dear Colleagues: We write to update you on a recent development concerning our Life Sciences Institute. After long deliberation, Jack Dixon, the Institute's director, has decided to accept a position at UC-San Diego. This decision, which Jack reached with great difficulty, was informed in large measure by personal reasons. Although we are very sorry to see Jack leave, we also understand his decision and wish him well. Jack has the Life Sciences Institute off to a tremendous start. Construction of the building is on schedule and on budget. Recruitment is in full swing, and we fully expect to open the Institute building a year from September, with a core faculty of six to ten. Fulfilling that goal will of course depend on our resolving quickly the succession of leadership in the Institute. We are both deeply engaged in this effort, assisted by Interim Provost Paul Courant. Its resolution has two parts. First, we are appointing an advisory committee of distinguished faculty to advise on directions for and leadership of the Institute, and subsequently, to advise and assist the Institute leadership on matters of science, recruitment and strategy. The initial members of this group are listed at the end of this message; additional faculty may be named in upcoming months. We have already held preliminary discussions with these faculty, and their advice is deeply informing our current thinking and actions with respect to the Institute. Second, within the next few weeks we will reach and announce decisions about the leadership of the Institute. We would like to note a couple of things in this context: We want to extend our deep appreciation to Jack Dixon for his leadership in the early development of the Life Sciences Institute. We want to express the University's strong commitment to the Institute's future, and our confidence in that future and the vital role the Institute will play in strengthening the life sciences at Michigan in the years ahead. We are excited by the prospects. And, we greatly appreciate the continuing leadership that will be provided by Alan Saltiel, Liz Barry, and the distinguished advisory committee named below. Sincerely,
Huda Akil, Ph.D. Carol Fierke, Ph.D. David Ginsburg, M.D. John Lowe, M.D. Rowena Matthews, Ph.D. Matthew O'Donnell, Ph.D. William Roush, Ph.D. Charles Yocum, Ph.D. | |||||